SOLV · 10-Q · 2026Q3 · Full report

Geographic Revenue Performance

Solventum Corp · 2026-11-05 · Importance 36 · Surprise 14

For the first nine months of 2026, U.S. net sales were $3,605 million, or 58.5% of worldwide sales, and organic growth was 4.5%; International sales were $2,560 million, or 41.5%, with organic growth of 0.7%. In the third quarter, U.S. organic sales declined 4.2% and International organic sales declined 1.0%, while reported sales fell 4.5% and 10.3%, respectively. U.S. quarterly weakness in MedSurg and Dental Solutions reflected approximately $125 million of second-quarter advanced ordering ahead of the July ERP deployment. International nine-month reported sales declined 9.0%, primarily reflecting divestiture effects despite organic growth.

Key facts

• Solventum's third-quarter U.S. organic sales declined in MedSurg and Dental Solutions because of approximately $125 million of second-quarter advanced customer ordering ahead of the July 2026 ERP deployment; the decline was partly offset by Health Information Systems growth. source
• Foreign currency translation positively impacted Health Information Systems sales by 0.4% in the first nine months of 2026. source
• In the third quarter of 2026, international organic sales declined in MedSurg and were partly offset by increases in Dental Solutions and Health Information Systems. source
• In the first nine months of 2026, U.S. organic sales growth occurred in all business segments and was led by MedSurg and Health Information Systems. source
• In the first nine months of 2026, international organic growth was led by Dental Solutions and Health Information Systems and was slightly offset by a MedSurg decline. source